Rebetron (interferon α -2b /ribavirin) / Merck (MSD), Bausch Health  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rebetron (interferon α -2b /ribavirin) / Merck (MSD), Bausch Health
NCT00727077: Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)

Terminated
N/A
3
Europe
IntronA (interferon alfa-2b; SCH 30500), SCH 30500, Rebetol (ribavirin; SCH 18908), SCH 18908
Merck Sharp & Dohme LLC
Hepatitis C, Chronic, Hepatitis C
06/07
06/07

Download Options